ClinicalTrials.govpublic full text
A Study to Rank Different Dosages of Antigen of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A), Based on Their Immune Response and Safety, When Administered to Healthy Adult Women
respiratory syncytial virus infections
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 208295
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.